Blueprint Medicines Corporation BPMC

Quarterly report 2025-Q1
added 05-01-2025

Blueprint Medicines Corporation DIO Ratio 2011-2026 | BPMC

Annual DIO Ratio Blueprint Medicines Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
315	1.09 K	528	309	3.68 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.68 K	309	1.19 K

Quarterly DIO Ratio Blueprint Medicines Corporation

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
433	-	645	275	746	-	549	678	679	-	536	281	467	-	383	220	11 K	-	5.36 K	6.17 K	16.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.3 K	220	2.8 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alnylam Pharmaceuticals ALNY	43.5	$ 330.79	3.74 %	$ 43.3 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aquestive Therapeutics AQST	120	$ 4.11	-0.48 %	$ 439 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Arcutis Biotherapeutics ARQT	185	$ 23.46	-0.72 %	$ 2.98 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Ardelyx ARDX	989	$ 6.01	1.18 %	$ 1.45 B	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA